Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1729 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Weill-Marchesani-like Syndrome | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Weill-Marchesani syndrome (WMS) is characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including ectopia lentis, severe myopia, glaucoma, and microspherophakia. Additionally, some patients have cardiac valvular abnormalities. Weill-Marchesani syndrome 1 (WMS1; MIM 277600) is an autosomal recessive disorder caused by mutations in the ADAMTS10 gene. Weill-Marchesani syndrome 2 (WMS2; MIM 608328) is a phenotypically similar autosomal dominant disorder caused by mutations in FBN1. A second autosomal recessive form of WMS, Weill-Marchesani syndrome 3 (WMS3; MIM 614819), is reportedly due to mutations in the LTBP2 gene. Mutations in LTBP2 appear to show variable expressivity as some affected individuals present with all the key features of WMS, while other affected individuals from the same family do not exhibit any eye findings. In addition to WMS3, mutations in LTBP2 also cause primary congenital glaucoma 3D (GLC3D; MIM 613086) and microspherophakia and/or megalocornea with ectopia lentis and with or without secondary glaucoma (MSPKA; MIM 251750). A Weill-Marchesani-like syndrome (MIM 613195) has also been described. This autosomal recessive disorder is caused by mutations in the ADAMTS17 gene. The clinical features of individuals with Weill-Marchesani-like syndrome include short stature and the eye abnormalities associated with WMS; however, these patients do not have brachydactyly or joint stiffness. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| ADAMTS17 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 613195 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Ophthalmology, Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.